loratadine has been researched along with Recrudescence in 11 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To demonstrate the treatment outcomes and dose reduction in desloratadine assessed using the urticarial activity score over 7 consecutive days." | 7.88 | The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria. ( Chaowattanapanit, S; Choonhakarn, C; Julanon, N, 2018) |
| "To demonstrate the treatment outcomes and dose reduction in desloratadine assessed using the urticarial activity score over 7 consecutive days." | 3.88 | The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria. ( Chaowattanapanit, S; Choonhakarn, C; Julanon, N, 2018) |
| "Loratadine treatment was not more sedative than placebo and was not associated with cardiovascular events." | 2.71 | Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. ( Adam, D; Bismut, H; Bonini, S; Borres, MP; Canonica, GW; Canseco Gonzalez, C; Czarlewski, W; Danzig, MR; Grimfeld, A; Holgate, ST; Lobaton, P; Patel, P; Roman, I; Szczeklik, A, 2004) |
| "The patient had a relapsing dermatosis beginning about 6 months before the diagnosis of the lung cancer, characterised by pruritic, erythematous plaques located on the trunk and arms." | 1.46 | Wells syndrome associated with lung cancer. ( Brito, C; Carvalho, SD; Ferreira, O; Santos, RP, 2017) |
| "Nearly 100 cases of atopic myelitis have been reported in Japan." | 1.37 | Atopic myelitis in a European woman residing in Japan. ( Bodini, B; Ciccarelli, O; Isaacs, JD; Scadding, GK; Thompson, AJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santos, RP | 1 |
| Carvalho, SD | 1 |
| Ferreira, O | 1 |
| Brito, C | 1 |
| Choonhakarn, C | 1 |
| Chaowattanapanit, S | 1 |
| Julanon, N | 1 |
| Gülen, T | 1 |
| Hägglund, H | 1 |
| Dahlén, SE | 1 |
| Sander, B | 1 |
| Dahlén, B | 1 |
| Nilsson, G | 1 |
| Ngamphaiboon, J | 1 |
| Wirawarn, T | 1 |
| Thongkaew, T | 1 |
| Isaacs, JD | 1 |
| Bodini, B | 1 |
| Ciccarelli, O | 1 |
| Scadding, GK | 1 |
| Thompson, AJ | 1 |
| Mulliez, P | 1 |
| Mbassi Fouda, FL | 1 |
| Roy Saint-Georges, F | 1 |
| Grimfeld, A | 1 |
| Holgate, ST | 1 |
| Canonica, GW | 1 |
| Bonini, S | 1 |
| Borres, MP | 1 |
| Adam, D | 1 |
| Canseco Gonzalez, C | 1 |
| Lobaton, P | 1 |
| Patel, P | 1 |
| Szczeklik, A | 1 |
| Danzig, MR | 1 |
| Roman, I | 1 |
| Bismut, H | 1 |
| Czarlewski, W | 1 |
| Tworek, D | 1 |
| Bocheńska-Marciniak, M | 1 |
| Kupczyk, M | 1 |
| Górski, P | 1 |
| Kuna, P | 1 |
| Mathews, J | 1 |
| Dangoisse, C | 1 |
| Meyvisch, K | 1 |
| Ledoux, M | 1 |
1 review available for loratadine and Recrudescence
| Article | Year |
|---|---|
[Airway hyperreactivity and respiratory allergy in children].
Topics: Allergens; Anti-Allergic Agents; Asthma; Bronchial Hyperreactivity; Chemotaxis, Leukocyte; Child; Ch | 1996 |
4 trials available for loratadine and Recrudescence
| Article | Year |
|---|---|
Prevention of recurrent wheezing in young children by loratadine compared with ketotifen.
Topics: Administration, Oral; Anti-Allergic Agents; Asthma; Child, Preschool; Double-Blind Method; Female; H | 2009 |
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study.
Topics: Anti-Allergic Agents; Asthma; Child, Preschool; Double-Blind Method; Female; Follow-Up Studies; Hist | 2004 |
The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis.
Topics: Adult; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Histamine H1 Antagon | 2007 |
[Airway hyperreactivity and respiratory allergy in children].
Topics: Allergens; Anti-Allergic Agents; Asthma; Bronchial Hyperreactivity; Chemotaxis, Leukocyte; Child; Ch | 1996 |
7 other studies available for loratadine and Recrudescence
| Article | Year |
|---|---|
Wells syndrome associated with lung cancer.
Topics: Administration, Topical; Biopsy; Cellulitis; Clobetasol; Dermatologic Agents; Eosinophilia; Humans; | 2017 |
The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria.
Topics: Adult; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Maintena | 2018 |
Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.
Topics: Acetates; Adult; Anaphylaxis; Cyclopropanes; Delayed Diagnosis; Drug Therapy, Combination; Epinephri | 2014 |
Atopic myelitis in a European woman residing in Japan.
Topics: Adrenal Cortex Hormones; Adult; Brain Stem; Europe; Female; Gait Disorders, Neurologic; Histamine H1 | 2011 |
[Cutaneous reaction after pyrazinamide initiation].
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Eruptions; Drug Therapy, Combination; Dysgeusi | 2011 |
Concern over Prozac-induced tumor growth may dwindle following FDA study.
Topics: Amitriptyline; Animals; Depression; Fluoxetine; Humans; Loratadine; Neoplasms; Recurrence; United St | 1995 |
Multiple eruptive keratoacanthoma and immunity disorders.
Topics: Aged; Antibodies, Antinuclear; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans; | 1993 |